Nanosuspension for the delivery of a poorly soluble anti-cancer kinase inhibitor.
European Journal of Pharmaceutics and Biopharmaceutics(2014)
Abstract
•We evaluate the anti-cancer multi-targeted kinase inhibitor, MTKi-327.•Various nanomedicines have been compared for the delivery of MTKi-321.•Nanosuspension is the most effective anti-cancer MTKi-327 delivery system.•MTKi-327 nanosuspension enhances the administered dose and the MTD.•MTKi-327 was evaluated in vivo: anti-tumor efficacy and pharmacokinetic studies.
MoreTranslated text
Key words
AUC,CL,DMEM,EDTA,EGFR,EMA,EPR,FDA,HPLC,IV,LOQ,MTD,NMR,PCL,PDI,PEG,PK,PLGA,PTX,PVDF,RES,SEC,SEM,TMC,VEGFR
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined